What is Callyope?
Based in France, Callyope operates at the intersection of medical technology and behavioral health. The company specializes in the development of advanced remote patient monitoring systems designed to provide objective insights into mental health conditions. By utilizing digital biomarkers and sophisticated analytics, Callyope enables clinicians to track patient progress with unprecedented precision, moving beyond traditional subjective assessments. This technological framework is essential for modernizing psychiatric care, offering a scalable solution that addresses the critical need for continuous, real-time monitoring in both clinical and home-based settings.
How much funding has Callyope raised?
Callyope has raised a total of $2.4M across 1 funding round:
Other Financing Round
$2.4M
Other Financing Round (2023): $2.4M with participation from No Label Ventures, Bpifrance, and 360 Capital Partners
Key Investors in Callyope
Bpifrance
Founded in 2012, Bpifrance is a French public investment bank that supports companies at every stage of development through credit, guarantees, and equity financing.
360 Capital Partners
A venture capital firm focused on innovation across Europe, particularly in France and Italy, with a strong track record of supporting high-growth technology companies.
No Label Ventures
An investment entity participating in the current funding round to support the advancement of Callyope's remote patient monitoring technology.
What's next for Callyope?
Looking ahead, the strategic deployment of this capital will likely focus on scaling operational capacity and expanding the company's footprint across European markets. As Callyope transitions into a more mature phase of its lifecycle, the focus will shift toward clinical validation and the integration of its monitoring platforms into broader healthcare ecosystems. The company is expected to prioritize the refinement of its diagnostic algorithms, potentially seeking further regulatory milestones to facilitate wider adoption among healthcare providers. By maintaining a rigorous focus on evidence-based outcomes, Callyope is poised to redefine the standard of care for patients suffering from chronic mental health disorders.
See full Callyope company page
